Main Article Content
Abstract
Atopic dermatitis is a chronic inflammatory skin disease that begins primarily in childhood with a mixed natural history. atopic dermatitis has increased over the past 30 years. It is currently estimated that 10-20% of children and 1-3% of adults in developed countries are affected by atopic dermatitis.
Knowing the characteristics and course of atopic dermatitis with a history of bronchial asthma based on: Gender, age, history of atopy, signs and symptoms, location of lesions and disease course and development including disease onset. This research method uses literature study. Where this research contains explanations, elaboration of theories, findings, and search results regarding topics written from books, journals, articles and research reports.
Researcher questions and topics are matched with specific keywords for research. These keywords are then used to search for articles on Google Scholar, PubMed, and Science Direct. These articles are then sorted and categorized into PRISMA diagrams. Then proceed with filtering and indexing articles on Scimago or SINTA. It was found that 15 of these indexing results were found in Scimago or SINTA.
Characteristics of atopic dermatitis with a history of bronchial asthma found the majority to occur in women. The onset begins in childhood, gets better in adolescence and then gets worse in adulthood. The characteristic lesions of atopic dermatitis, in which one reported dry and itchy skin to erythema, skin peeling, skin thickening, secretions, hyperpigmentation, and lichenification. There is an increase in IgE and pro-Th2 cytokine levels, based on the therapy the majority indicate the use of corticosteroids.
Keywords : atopic dermatitis, asthma bronchiale, allergy
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
[2] S. Kapur, W. Watson, and S. Carr, “Atopic dermatitis,” Allergy, Asthma & Clinical Immunology, vol. 14, no. S2, p. 52, Sep. 2018, doi: 10.1186/s13223-018-0281-6.
[3] R. Al-Adawiyah, A. M. Putera, L. Astari, and F. C. Ariyanto, “Determinant factors of recurrence atopic dermatitis symptoms in children: A cross-sectional study,” Annals of Medicine and Surgery, vol. 70, p. 102847, 2021, doi: https://doi.org/10.1016/j.amsu.2021.102847.
[4] P. Y. Ong, “Moving toward a more precise treatment of atopic dermatitis,” Annals of Allergy, Asthma & Immunology, vol. 120, no. 1, pp. 3–4, Jan. 2018, doi: 10.1016/j.anai.2017.10.013.
[5] N. M. Ibrahim, F. I. Almarzouqi, F. A. al Melaih, H. Farouk, M. Alsayed, and F. M. AlJassim, “Prevalence of asthma and allergies among children in the United Arab Emirates: A cross-sectional study,” World Allergy Organization Journal, vol. 14, no. 10, p. 100588, 2021, doi: https://doi.org/10.1016/j.waojou.2021.100588.
[6] J. Čelakovská, J. Bukač, R. Vaňková, I. Krcmova, J. Krejsek, and C. Andrýs, “Sensitisation to molecular components in patients with atopic dermatitis, relation to asthma bronchiale and allergic rhinitis,” Food Agric Immunol, vol. 31, no. 1, pp. 600–629, Jan. 2020, doi: 10.1080/09540105.2020.1747406.
[7] Y. Nakamura et al., “Japanese guidelines for adult asthma 2020,” Allergology International, vol. 69, no. 4, pp. 519–548, Oct. 2020, doi: 10.1016/j.alit.2020.08.001.
[8] T.-C. Yao et al., “Taiwan guidelines for the diagnosis and management of pediatric atopic dermatitis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology,” Journal of Microbiology, Immunology and Infection, Apr. 2022, doi: 10.1016/j.jmii.2022.03.004.
[9] I. M. Kardana, “Dermatitis atopi pada bayi usia 0- ¬ 12 bulan kelahiran RSUP Sanglah Denpasar dengan riwayat atopi keluarga antara bulan Desember 2015- ¬ Januari 2016,” vol. 11, no. 3, pp. 1045–1048, 2020, doi: 10.15562/ism.v11i3.205.
[10] W. T. Nugroho et al., “Characteristics of Atopic Dermatitis Patients who Underwent Skin Prick Test,” Berkala Ilmu Kesehatan Kulit dan Kelamin, vol. 34, no. 1, pp. 10–14, Mar. 2022, doi: 10.20473/bikk.V34.1.2022.10-14.
[11] C. Venter et al., “Incidence and timing of offspring asthma, wheeze, allergic rhinitis, atopic dermatitis, and food allergy and association with maternal history of asthma and allergic rhinitis,” World Allergy Organization Journal, vol. 14, no. 3, p. 100526, Mar. 2021, doi: 10.1016/j.waojou.2021.100526.
[12] H. Murota, Y. Koike, H. Morisaki, M. Matsumoto, and M. Takenaka, “Exacerbating factors and disease burden in patients with atopic dermatitis,” Allergology International, vol. 71, no. 1, pp. 25–30, Jan. 2022, doi: 10.1016/j.alit.2021.10.002.
[13] M. Yaneva and R. Darlenski, “The link between atopic dermatitis and asthma- immunological imbalance and beyond,” Asthma Res Pract, vol. 7, no. 1, p. 16, Dec. 2021, doi: 10.1186/s40733-021-00082-0.
[14] N. Ravnborg et al., “Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis,” J Am Acad Dermatol, vol. 84, no. 2, pp. 471–478, Feb. 2021, doi: 10.1016/j.jaad.2020.02.055.
[15] M. N. Basu, C. G. Mortz, T. K. Jensen, T. Barington, K. L. Lambertsen, and S. Halken, “Biomarkers in asthma in the context of atopic dermatitis in young children,” Pediatric Allergy and Immunology, vol. 33, no. 7, Jul. 2022, doi: 10.1111/pai.13823.
[16] A. Effendi, E. Silvia, Y. Nurmalasari, and J. Lawren, “Hubungan Antara Jenis Kelamin dengan Angka Kejadian Dermatitis Atopik di Poliklinik Kulit dan Kelamin Rumah Sakit Umum Daerah Dr. H. Abdul Moeloek Provinsi Lampung Tahun 2019,” J Med Malahayati, vol. 4, no. 2, pp. 104–111, 2020.
[17] A. A. Justiz Vaillant, P. Modi, and A. Jan, Atopy. 2022. [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/31194344
[18] N. Maiello, P. Comberiati, A. Giannetti, G. Ricci, R. Carello, and E. Galli, “New Directions in Understanding Atopic March Starting from Atopic Dermatitis,” Children, vol. 9, no. 4, p. 450, Mar. 2022, doi: 10.3390/children9040450.
[19] “Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT Study,” J Investig Allergol Clin Immunol, vol. 31, no. 3, pp. 236–245, Jun. 2021, doi: 10.18176/jiaci.0478.
[20] R. Tanei, “Atopic Dermatitis in Older Adults: A Review of Treatment Options,” Drugs Aging, vol. 37, no. 3, pp. 149–160, Mar. 2020, doi: 10.1007/s40266-020-00750-5.
[21] M. A. McAleer, G. M. O’Regan, and A. D. Irvine, “Atopic Dermatitis,” in Dermatology, 4th ed., Elsevier, 2017, pp. 208–227.
[22] W. D. James, D. M. Elston, J. R. Treat, M. A. Rosenbach, and I. M. Neuhaus, Andrews’ Diseases of the Skin: Clinical Dermatology. Elsevier, 2020.
[23] W. Frazier and N. Bhardwaj, “Atopic Dermatitis: Diagnosis and Treatment.,” Am Fam Physician, vol. 101, no. 10, pp. 590–598, May 2020, [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/32412211
[24] M. Fujii, “Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus,” Biol Pharm Bull, vol. 43, no. 1, pp. 12–19, Jan. 2020, doi: 10.1248/bpb.b19-00088.